10th Jan 2012 18:22
This announcement replaces the original announcement released on 3 January 2012 at 17.30 (RNS No: 9377U).
Due to an administrative error the change in one of the Non-Executive Director's interests in the American Depositary Shares (ADSs) of GlaxoSmithKline plc indicated with an asterisk (*) below, was incorrectly stated in the announcement made on 3 January 2012.
Save as disclosed above, all other details remain unchanged. The full amended text is shown below.
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 30 December 2011, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares and American Depositary Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2011:
GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award- Annual Dividend Reinvestment
Non-Executive Director | No. of Ordinary Shares | Average Price (£) | No. of ADSs | Average Price ($) |
Sir Christopher Gent | 3,072.732 | 14.70 | ||
Prof Sir Roy Anderson | 408.069 | 14.70 | ||
Dr Stephanie Burns | 361.105 | 45.53 | ||
Ms Stacey Cartwright | 3.865 | 14.70 | ||
Mr Lawrence Culp | 1,133.685 | 45.53 | ||
Sir Crispin Davis | 2,536.065 | 14.70 | ||
Ms Judy Lewent | 1.998* | 45.53 | ||
Sir Deryck Maughan | 1,033.536 | 45.53 | ||
Mr James Murdoch | 474.157 | 14.70 | ||
Dr Daniel Podolsky | 623.023 | 45.53 | ||
Mr Tom de Swaan | 612.754 | 14.70 | ||
Sir Robert Wilson | 710.997 | 14.70 |
The Company and the Non-Executive Directors were informed of these allocations on
3 January 2012.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
10 January 2012
Related Shares:
Glaxosmithkline